Posterior Wall Isolation Improves Outcomes for Persistent AF With Rapid Posterior Wall Activity: A CAPLA Substudy
Louise Segan,David Chieng,Sandeep Prabhu,Andrew Hunt,Troy Watts,Brian Klys,Aleksandr Voskoboinik,Hariharan Sugumar,Liang-Han Ling,Geoff Lee,Joseph Morton,Rajeev K Pathak,Deep Chandh Raja,Laurence Sterns,Matthew Ginks,Prashanthan Sanders,Jonathan M Kalman,Peter M Kistler,Geoff Lee MBChD,Rajeev K. Pathak,Jonathan M. Kalman,Peter M. Kistler
DOI: https://doi.org/10.1016/j.jacep.2023.08.018
2023-08-27
Abstract:Background Pulmonary vein isolation (PVI) is less effective in persistent AF (PerAF) than in paroxysmal AF. However, the CAPLA randomized trial of PVI vs posterior wall isolation (PWI) did not support empiric PWI in PerAF. We examined PV and posterior wall (PW) electrical characteristics to determine if select patients may benefit from additional PWI. Objective Determine the impact of PV and PW electrical characteristics on AF ablation outcomes in the CAPLA randomized study. Methods Participants in spontaneous AF at the time of ablation were included from the CAPLA study. The mean, shortest and longest PV, PW and left atrial appendage (LAA) cycle length (CL) measurements were annotated pre-ablation using a multipolar catheter for 100 consecutive cycles. Next cardioversion was performed with a high density left atrial voltage map completed. Cox proportional hazards regression was utilised to determine clinical and electroanatomic(EA) predictors of AF recurrence overall and according to ablation strategy. Follow up included twice daily single lead ECGs or continuous monitoring for 12 months. Results A total of 151 patients (27% female, 65±9 years, 18% LsPerAF, LAVI 52±16ml/m 2 , median AF duration 5 months [IQR 2-10]) were in AF on the day of procedure and were randomized to PVI alone (50%) or PVI+PWI (50%) according to the CAPLA study protocol. Baseline clinical, echocardiographic and EA parameters were comparable between groups (all p>0.05, table 1) including PV and PW characteristics. After 12 months, freedom from AF off antiarrhythmic drug therapy was 51.7% in PVI and 49.7% in PVI+PWI (Log Rank p =0.564). Rapid PW activity was defined as less than the median of the shortest PWCL (140ms) and rapid PV activity was defined as less than the median of the shortest PVCL (126ms). In those with rapid PW activity, the addition of PWI was associated with greater arrhythmia-free survival (56.4%) vs PVI alone (38.6%; HR 0.78, 95% CI 0.67-0.94, Log Rank p=0.030). Moreover, in those undergoing PVI only, the risk of AF recurrence was higher in those with rapid PW activity (55.3% vs 46.5% in slower PW activity; HR 1.50, 95%CI 1.11-2.26, Log Rank p=0.036). Rapid PV activity and PVCL (individual PVs or average of all 4 PVs) were not associated with outcome (all p>0.05) regardless of ablation strategy. There was no correlation between PWCL and posterior low voltage (r=-0.06, p=0.496). The addition of PWI did not improve arrhythmia-free survival in subgroups with LA enlargement (LAVI>34ml/m 2 ) HR 0.69, 95% CI 0.39-1.25, p=0.301), posterior LVZ (HR 1.06, 95% CI 0.68-1.66, p=0.807) or LsPerAF (HR 1.10, 95% CI 0.71-1.72, p=0.669). Conclusion Rapid PW activity is associated with an increased risk of AF recurrence post catheter ablation. The addition of PWI in this subgroup was associated with a significant improvement in freedom from AF compared to PVI alone. The presence of rapid PW activity may identify patients with persistent AF likely to benefit from PWI.
cardiac & cardiovascular systems